Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes

Cancer Statistics, 2017.

Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969

Genomic analyses identify molecular subtypes of pancreatic cancer

Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621

Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer

Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Whole genomes redefine the mutational landscape of pancreatic cancer

Initiative, A. P. C. G., Waddell, N., Pajic, M., Patch, A.-M., Chang, D. K., Kassahn, K. S., Bailey, P., Johns, A. L., Miller, D., Nones, K., et al. (2015) · Nature · doi:10.1038/nature14169 · Cited by 2,642

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

Rhim, A. D., Oberstein, P. E., Thomas, D. H., Mirek, E. T., Palermo, C. F., Sastra, S. A., Dekleva, E. N., Saunders, T., Becerra, C. P., Tattersall, I. W., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.021 · Cited by 2,085

Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes

Initiative, A. P. C. G., Biankin, A. V., Waddell, N., Kassahn, K. S., Gingras, M.-C., Muthuswamy, L. B., Johns, A. L., Miller, D. K., Wilson, P. J., Patch, A.-M., et al. (2012) · Nature · doi:10.1038/nature11547 · Cited by 2,058

Integrated genomic characterization of pancreatic ductal adenocarcinoma

Raphael, B. J., Hruban, R. H., Aguirre, A. J., Moffitt, R. A., Yeh, J. J., Stewart, C., Robertson, A. G., Cherniack, A. D., Gupta, M., Getz, G., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.07.007 · Cited by 2,019

Pancreatic cancer: Advances and challenges

Halbrook, C. J., Lyssiotis, C. A., Pasca di Magliano, M., & Maitra, A. (2023) · Cell · doi:10.1016/j.cell.2023.02.014 · Cited by 1,321

Diversity and biology of cancer-associated fibroblasts

Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265

Cross-tissue organization of the fibroblast lineage

Buechler, M. B., Pradhan, R., Krishnamurty, A. T., Cox, C. B., Calviello, A. K., Wang, A. W., Yang, Y. A., Tam, L., Caothien, R. H., Roose‐Girma, M., et al. (2021) · Nature · doi:10.1038/s41586-021-03549-5 · Cited by 1,100

Single-cell RNA sequencing reveals stromal evolution into LRRC15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy

Dominguez, C. X., Müller, S., Keerthivasan, S., Koeppen, H., Hung, J., Gierke, S., Breart, B., Foreman, O., Bainbridge, T. W., Castiglioni, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0644 · Cited by 857

Proteogenomic characterization of pancreatic ductal adenocarcinoma

Cao, L., Huang, C., Cui Zhou, D., Hu, Y., Lih, T. M., Savage, S. R., Krug, K., Clark, D. J., Schnaubelt, M., Chen, L., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.023 · Cited by 578

Accurate and efficient detection of gene fusions from RNA sequencing data

Uhrig, S., Ellermann, J., Walther, T., Burkhardt, P., Fröhlich, M., Hutter, B., Toprak, U. H., Neumann, O., Stenzinger, A., Scholl, C., et al. (2021) · Genome Research · doi:10.1101/gr.257246.119 · Cited by 526

LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity

Krishnamurty, A. T., Shyer, J. A., Thai, M., Gandham, V., Buechler, M. B., Yang, Y. A., Pradhan, R. N., Wang, A. W., Sanchez, P. L., Qu, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-05272-1 · Cited by 436

Spatially confined sub-tumor microenvironments in pancreatic cancer

Grünwald, B. T., Devisme, A., Andrieux, G., Vyas, F., Aliar, K., McCloskey, C. W., Macklin, A., Jang, G. H., Denroche, R., Romero, J. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.022 · Cited by 433

The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives

Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369

Microenvironmental Determinants of Pancreatic Cancer

Heßmann, E., Buchholz, S., Demir, İ. E., Singh, S. K., Gress, T. M., Ellenrieder, V., & Neeße, A. (2020) · Physiological Reviews · doi:10.1152/physrev.00042.2019 · Cited by 336

Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer

Zhou, D. C., Jayasinghe, R. G., Chen, S., Herndon, J. M., Iglesia, M. D., Navale, P., Wendl, M. C., Caravan, W., Sato, K., Storrs, E. P., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01157-1 · Cited by 290

Purity Independent Subtyping of Tumors (PurIST), A Clinically Robust, Single-sample Classifier for Tumor Subtyping in Pancreatic Cancer

Rashid, N. U., Peng, X. L., Jin, C., Moffitt, R. A., Volmar, K. E., Belt, B. A., Panni, R. Z., Nywening, T. M., Herrera, S. G., Moore, K. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1467 · Cited by 239

The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer

Michaelis, K. A., Norgard, M. A., Zhu, X., Levasseur, P. R., Sivagnanam, S., Liudahl, S. M., Burfeind, K. G., Olson, B. G., Pelz, K. R., Ramos, D. M. A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12657-w · Cited by 231

Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer

Wasko, U. N., Jiang, J., Dalton, T. C., Curiel-Garcia, A., Edwards, A. C., Wang, Y., Lee, B., Orlen, M., Tian, S., Stalnecker, C. A., et al. (2024) · Nature · doi:10.1038/s41586-024-07379-z · Cited by 209

Tumour-reprogrammed stromal BCAT1 fuels branched-chain ketoacid dependency in stromal-rich PDAC tumours

Zhu, Z., Achreja, A., Meurs, N., Animasahun, O., Owen, S., Mittal, A., Parikh, P., Lo, T.-W., Franco-Barraza, J., Shi, J., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0226-5 · Cited by 204

Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1

Kemp, S. B., Carpenter, E. S., Steele, N. G., Donahue, K. L., Nwosu, Z. C., Pacheco, A., Velez-Delgado, A., Menjivar, R. E., Lima, F., The, S., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3929 · Cited by 197

Targeting DNA Damage Response and Replication Stress in Pancreatic Cancer

Dreyer, S. B., Upstill‐Goddard, R., Paulus-Hock, V., Paris, C., Lampraki, E.-M., Dray, E. V., Serrels, B., Caligiuri, G., Rebus, S., Plenker, D., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.09.043 · Cited by 165

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

Sharbeen, G., McCarroll, J. A., Akerman, A., Kopecky, C., Youkhana, J., Kokkinos, J., Holst, J., Boyer, C. A., Erkan, M., Goldstein, D., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2496 · Cited by 135

Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes

Miyabayashi, K., Baker, L. A., Deschênes, A., Traub, B., Caligiuri, G., Plenker, D., Alagesan, B., Belleau, P., Li, S., Kendall, J., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0133 · Cited by 124

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

Klomp, J. A., Klomp, J. E., Stalnecker, C. A., Bryant, K. L., Edwards, A. C., Drizyte‐Miller, K., Hibshman, P. S., Diehl, J. N., Lee, Y. S., Morales, A. J., et al. (2024) · Science · doi:10.1126/science.adk0775 · Cited by 139

Aggressive PDACs Show Hypomethylation of Repetitive Elements and the Execution of an Intrinsic IFN Program Linked to a Ductal Cell of Origin

Espinet, E., Gu, Z., Imbusch, C. D., Giese, N. A., Büscher, M., Safavi, M., Weisenburger, S., Klein, C., Vogel, V., Falcone, M., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1202 · Cited by 124

Cell of origin influences pancreatic cancer subtype

Flowers, B. M., Xu, H., Mulligan, A. S., Hanson, K. J., Seoane, J. A., Vogel, H., Curtis, C., Wood, L. D., & Attardi, L. D. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0633 · Cited by 118

TNF-α-producing macrophages determine subtype identity and prognosis via AP1 enhancer reprogramming in pancreatic cancer

Tu, M., Klein, L., Espinet, E., Georgomanolis, T., Wegwitz, F., Li, X., Urbach, L., Danieli‐Mackay, A., Küffer, S., Bojarczuk, K., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00258-w · Cited by 115

Tumor-associated macrophages in pancreatic ductal adenocarcinoma: therapeutic opportunities and clinical challenges

Poh, A. R., & Ernst, M. (2021) · Cancers · doi:10.3390/cancers13122860 · Cited by 106

N 6 -methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression

Tian, J., Zhu, Y., Rao, M., Cai, Y., Lu, Z., Zou, D., Peng, X., Ying, P., Zhang, M., Niu, S., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320179 · Cited by 97

Matrix stiffness drives stromal autophagy and promotes formation of a protumorigenic niche

Hupfer, A., Brichkina, A. I., Koeniger, A., Keber, C. U., Denkert, C., Pfefferle, P. I., Helmprobst, F., Pagenstecher, A., Visekruna, A., & Lauth, M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2105367118 · Cited by 101

Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation

Somerville, T. D. D., Biffi, G., Daßler‐Plenker, J., Hur, S. K., He, X., Vance, K. E., Miyabayashi, K., Xu, Y., Maia-Silva, D., Klingbeil, O., et al. (2020) · eLife · doi:10.7554/elife.53381 · Cited by 87

Tuft Cells Inhibit Pancreatic Tumorigenesis in Mice by Producing Prostaglandin D2

DelGiorno, K. E., Chung, C., Vavinskaya, V., Maurer, H. C., Novak, S. W., Lytle, N. K., Ma, Z., Giraddi, R. R., Wang, D., Fang, L., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.07.037 · Cited by 82

Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression

Cheung, P. F., Yang, J., Fang, R., Borgers, A., Krengel, K., Stoffel, A., Althoff, K., Yip, C. W., Siu, E. H.-L., Ng, L. W. C., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27088-9 · Cited by 84

Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype

Oh, K., Yoo, Y. J., Torre-Healy, L. A., Rao, M., Fassler, D., Wang, P., Caponegro, M. D., Gao, M., Kim, J., Sasson, A. R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40895-6 · Cited by 85

Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems

Dijk, F., Veenstra, V. L., Soer, E. C., Dings, M. P. G., Zhao, L., Halfwerk, J. B. G., Hooijer, G. K. J., Damhofer, H., Marzano, M., Steins, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-019-56826-9 · Cited by 77

Different shades of pancreatic ductal adenocarcinoma, different paths towards precision therapeutic applications

Martens, S., Lefesvre, P., Nicolle, R., Biankin, A. V., Puleo, F., Laethem, J. V., & Rooman, I. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz181 · Cited by 78

Clinical Impact of Molecular Subtyping of Pancreatic Cancer

Zhou, X., Hu, K., Bailey, P. J., Springfeld, C., Roth, S., Kurilov, R., Brors, B., Gress, T. M., Buchholz, M., An, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.743908 · Cited by 84

Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies

Pereira, M. A., & Chio, I. I. C. (2019) · Genes · doi:10.3390/genes11010006 · Cited by 75

The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients

Meng, Z., Yuan, Q., Zhao, J., Wang, B., Li, S., Offringa, R., Jin, X., & Wu, H. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.04.011 · Cited by 72

Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions

Boelaars, K., Rodríguez, E., Huinen, Z. R., Liu, C., Wang, D., Springer, B. O., Olesek, K., Kruijssen, L. J. W., van Ee, T., Lindijer, D., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06087-8 · Cited by 75

Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinomaPreprint

Venkat, S., Tisdale, A. A., Schwarz, J. R., Alahmari, A. A., Maurer, H. C., Olive, K. P., Eng, K. H., & Feigin, M. E. (2020) · Genome Research · doi:10.1101/gr.257550.119 · Cited by 72

Mechanisms of PDAC subtype heterogeneity and therapy response

Espinet, E., Klein, L., Puré, E., & Singh, S. K. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.08.005 · Cited by 70

Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets

Large, T. Y. S. L., Mantini, G., Meijer, L. L., Pham, T. V., Funel, N., van Grieken, N. C. T., Kok, B., Knol, J. C., van Laarhoven, H. W. M., Piersma, S. R., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138290 · Cited by 62

ZBED2 is an antagonist of interferon regulatory factor 1 and modifies cell identity in pancreatic cancer

Somerville, T. D. D., Xu, Y., Wu, X., Maia-Silva, D., Hur, S. K., de Almeida, L. M. N., Preall, J. B., Koo, P. K., & Vakoc, C. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921484117 · Cited by 60

The vascular landscape of human cancer

Kahn, B., Lucas, A., Alur, R. G., Wengyn, M. D., Schwartz, G. W., Li, J., Sun, K., Maurer, H. C., Olive, K. P., Faryabi, R. B., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136655 · Cited by 59

Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes

Hyeon, D. Y., Nam, D., Han, Y., Kim, D. K., Kim, G., Kim, D., Bae, J., Back, S., Mun, D., Madar, I. H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00479-7 · Cited by 57

Pre-clinical Models of Metastasis in Pancreatic Cancer

Miquel, M., Zhang, S., & Pilarsky, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.748631 · Cited by 53

Clinical functional proteomics of intercellular signalling in pancreatic cancer

Huang, P., Gao, W., Fu, C., Wang, M., Li, Y., Chu, B., He, A., Li, Y., Deng, X., Zhang, Y., et al. (2024) · Nature · doi:10.1038/s41586-024-08225-y · Cited by 52

Metastatic phenotype and immunosuppressive tumour microenvironment in pancreatic ductal adenocarcinoma: Key role of the urokinase plasminogen activator (PLAU)

Hosen, S. M. Z., Uddin, M. N., Xu, Z., Buckley, B. J., Perera, C. J., Pang, T., Mekapogu, A. R., Moni, M. A., Notta, F., Gallinger, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1060957 · Cited by 50

The Role of the Microbiome in Pancreatic Cancer

Miyabayashi, K., Ijichi, H., & Fujishiro, M. (2022) · Cancers · doi:10.3390/cancers14184479 · Cited by 48

Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine

Liotta, L. A., Pappalardo, P. A., Carpino, A., Haymond, A. N., Howard, M., Espina, V. A., Wulfkuhle, J., & Petricoin, E. F. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1984886 · Cited by 45

Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial

Nicolle, R., Bachet, J., Harlé, A., Iovanna, J., Hammel, P. R., Rebours, V., Turpin, A., Abdelghani, M. B., Wei, A. C.-C., Mitry, E., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02668 · Cited by 40

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification

Espiau-Romera, P., Courtois, S., Parejo-Alonso, B., & Sancho, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9124128 · Cited by 43

Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact

Gutiérrez, M. L., Muñoz‐Bellvís, L., & Órfão, A. (2021) · Cancers · doi:10.3390/cancers13174451 · Cited by 41

Dynamic Stromal Alterations Influence Tumor-Stroma Crosstalk to Promote Pancreatic Cancer and Treatment Resistance

Murphy, K. J., Chambers, C. R., Herrmann, D., Timpson, P., & Pereira, B. (2021) · Cancers · doi:10.3390/cancers13143481 · Cited by 37

Secretome of Stromal Cancer-Associated Fibroblasts (CAFs): Relevance in Cancer

Mishra, D., & Banerjee, D. (2023) · Cells · doi:10.3390/cells12040628 · Cited by 38

Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer

Scales, M. K., Velez-Delgado, A., Steele, N. G., Schrader, H. E., Stabnick, A. M., Yan, W., Mercado-Soto, N. M., Nwosu, Z., Johnson, C. N., Zhang, Y.-Q., et al. (2022) · PLoS Genetics · doi:10.1371/journal.pgen.1010315 · Cited by 28

Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation

Swietlik, J. J., Bärthel, S., Falcomatà, C., Fink, D., Sinha, A., Cheng, J., Ebner, S., Landgraf, P., Dieterich, D. C., Daub, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38171-8 · Cited by 38

Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer

Carter, E. P., Coetzee, A. S., Bort, E. T., Wang, Q., Kocher, H. M., & Grose, R. P. (2021) · Cells · doi:10.3390/cells10040847 · Cited by 34

A mucus production programme promotes classical pancreatic ductal adenocarcinoma

Tonelli, C., Yordanov, G. N., Hao, Y., Deschênes, A., Hinds, J., Belleau, P., Klingbeil, O., Brosnan, E., Doshi, A., Park, Y., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-329839 · Cited by 34

Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages

Samain, R., Brunel, A., Douché, T., Fanjul, M., Cassant‐Sourdy, S., Rochotte, J., Cros, J. F., Neuzillet, C., Raffenne, J., Duluc, C., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.01.008 · Cited by 32

An Integrated Meta-Analysis of Secretome and Proteome Identify Potential Biomarkers of Pancreatic Ductal Adenocarcinoma

de Oliveira, G., Freire, P. P., Cury, S. S., de Moraes, D., Oliveira, J. S., Dal‐Pai‐Silva, M., Reis, P. P., & Carvalho, R. F. (2020) · Cancers · doi:10.3390/cancers12030716 · Cited by 34

Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)

Zuzčák, M., & Trnka, J. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5383 · Cited by 33

Gene Targeting in Disease Networks

Weighill, D. A., Guebila, M. B., Glass, K., Platig, J., Yeh, J. J., & Quackenbush, J. F. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.649942 · Cited by 30

Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study

Suurmeijer, J. A., Soer, E. C., Dings, M. P. G., Kim, Y., Strijker, M., Bonsing, B. A., Brosens, L. A. A., Busch, O. R., Groen, J. V., Halfwerk, J. B. G., et al. (2022) · British journal of surgery · doi:10.1093/bjs/znac272 · Cited by 30

Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence

Sántha, P., Lenggenhager, D. M., Finstadsveen, A. V., Dorg, L. T., Tøndel, K., Amrutkar, M., Gladhaug, I. P., & Verbeke, C. S. (2021) · Cancers · doi:10.3390/cancers13040895 · Cited by 33

SPARC dependent collagen deposition and gemcitabine delivery in a genetically engineered mouse model of pancreas cancer

Ramu, I., Buchholz, S. M., Patzak, M. S., Goetze, R. G., Singh, S. K., Richards, F. M., Jodrell, D. I., Sipos, B., Ströbel, P., Ellenrieder, V., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.024 · Cited by 29

GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets

Sriram, K., Salmerón, C., Wiley, S. Z., & Insel, P. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15028 · Cited by 29

Molecular and Phenotypic Profiling for Precision Medicine in Pancreatic Cancer: Current Advances and Future Perspectives

Miyabayashi, K., Nakagawa, H., & Koike, K. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682872 · Cited by 28

Pancreatic Organoids for Regenerative Medicine and Cancer Research

Casamitjana, J., Espinet, E., & Rovira, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.886153 · Cited by 29

ROR2 Regulates Cellular Plasticity in Pancreatic Neoplasia and Adenocarcinoma

Benitz, S., Steep, A., Nasser, M. M., Preall, J. B., Mahajan, U. M., McQuithey, H., Loveless, I. M., Davis, E. T., Wen, H.-J., Long, D. W., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0137 · Cited by 29

Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma

Birnbaum, D. J., Begg, S. K. S., Finetti, P., Vanderburg, C. R., Kulkarni, A. S., Neyaz, A., Hank, T. P., Tai, E. C., Deshpande, V., Bertucci, F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1039 · Cited by 27

A Tumor Microenvironment Model of Pancreatic Cancer to Elucidate Responses toward Immunotherapy

Kast, V., Nadernezhad, A., Pette, D., Gabrielyan, A., Fusenig, M., Honselmann, K. C., Stange, D. E., Werner, C., & Loessner, D. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201907 · Cited by 27

Open-source curation of a pancreatic ductal adenocarcinoma gene expression analysis platform (pdacR) supports a two-subtype model

Torre-Healy, L. A., Kawalerski, R. R., Oh, K., Chrastecka, L., Peng, X. L., Aguirre, A. J., Rashid, N. U., Yeh, J. J., & Moffitt, R. A. (2023) · Communications Biology · doi:10.1038/s42003-023-04461-6 · Cited by 28

Pervasiveness of HLA allele-specific expression loss across tumor types

Filip, I., Wang, A., Kravets, O., Orenbuch, R., Zhao, J., Perea-Chamblee, T. E., Manji, G. A., de Maturana, E. L., Malats, N., Olive, K. P., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01154-x · Cited by 24

Improving the prognosis of pancreatic cancer: insights from epidemiology, genomic alterations, and therapeutic challenges

Jiang, Z., Zheng, X., Li, M., & Liu, M. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-1050-6 · Cited by 24

The Gut Microbiome and Pancreatic Cancer Development and Treatment

Attebury, H., & Daley, D. (2023) · The Cancer Journal · doi:10.1097/ppo.0000000000000647 · Cited by 24

Drivers of Gene Expression Dysregulation in Pancreatic Cancer

Venkat, S., Alahmari, A. A., & Feigin, M. E. (2021) · Trends in cancer · doi:10.1016/j.trecan.2021.01.008 · Cited by 23

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer

Singh, H. M., Leber, M. F., Bossow, S., Engeland, C. E., Dessila, J., Grossardt, C., Zaoui, K., Bell, J. C., Jäger, D., Kalle, C. V., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.04.015 · Cited by 23

Targeting the Stroma in the Management of Pancreatic Cancer

Edwards, P., Kang, B. W., & Chau, I. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.691185 · Cited by 22

Developmental and MAPK-responsive transcription factors drive distinct malignant subtypes and genetic dependencies in pancreatic cancerPreprint

Laise, P., Turunen, M. M., Garcia, A. C., Tomassoni, L., Maurer, H. C., Elyada, E., Schmierer, B., Worley, J., Kesner, J. S., Tan, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.27.357269 · Cited by 21

FAK promotes stromal PD-L2 expression associated with poor survival in pancreatic cancer

Davidson, C., Taggart, D., Sims, A. H., Lonergan, D. W., Canel, M., & Serrels, A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01966-5 · Cited by 20

Wnt-deficient and hypoxic environment orchestrates squamous reprogramming of human pancreatic ductal adenocarcinoma

Tamagawa, H., Fujii, M., Togasaki, K., Seino, T., Kawasaki, S., Takano, A., Toshimitsu, K., Takahashi, S., Ohta, Y., Matano, M., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01498-5 · Cited by 22

CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma

Cannon, A. C., Thompson, C. M., Maurer, H. C., Atri, P., Bhatia, R., West, S. C., Ghersi, D., Olive, K. P., Sushil Kumar, K., & Batra, S. K. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1359 · Cited by 19

Deconstructing Pancreatic Cancer Using Next Generation-Omic Technologies–From Discovery to Knowledge-Guided Platforms for Better Patient Management

Schreyer, D., Neoptolemos, J. P., Barry, S. T., & Bailey, P. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.795735 · Cited by 19

Serum levels of iCAF ‐derived osteoglycin predict favorable outcome in pancreatic cancer

Dings, M. P. G., Manoukian, P., Waasdorp, C., Quik, J. S. E., Strijker, M., Lodestijn, S. C., van Neerven, S. M., Moreno, L. F., de Oliveira, R. L., Bonsing, B. A., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34276 · Cited by 19

Laser Capture Microdissection: A Gear for Pancreatic Cancer Research

Rao, B. H., Souček, P., & Hlaváč, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314566 · Cited by 19

Transcriptomic subtyping of gastrointestinal malignancies

de Back, T. R., van Hooff, S. R., Sommeijer, D. W., & Vermeulen, L. (2024) · Trends in cancer · doi:10.1016/j.trecan.2024.06.007 · Cited by 19

Axon guidance receptor ROBO3 modulates subtype identity and prognosis via AXL-associated inflammatory network in pancreatic cancer

Krebs, N., Klein, L., Wegwitz, F., Espinet, E., Maurer, H. C., Tu, M., Penz, F., Küffer, S., Xu, X., Bohnenberger, H., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.154475 · Cited by 16

A tangled tale of molecular subtypes in pancreatic cancer

Singh, S. K., Hasselluhn, M. C., & Neeße, A. (2019) · Gut · doi:10.1136/gutjnl-2018-318086 · Cited by 16

Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion

Bort, E. T., Joseph, M. D., Wang, Q., Carter, E. P., Roth, N. J., Gibson, J., Samadi, A., Kocher, H. M., Simoncelli, S., McCormick, P. J., et al. (2023) · eLife · doi:10.7554/elife.86971 · Cited by 15

Interferon regulatory factor 1 (IRF1) controls the metabolic programmes of low-grade pancreatic cancer cells

Alfarano, G., Audano, M., Chiaro, P. D., Balestrieri, C., Milan, M., Polletti, S., Spaggiari, P., Zerbi, A., Diaferia, G. R., Mitro, N., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-325811 · Cited by 17

Precision Medicine in Pancreatic Disease—Knowledge Gaps and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop

Lowe, M. E., Andersen, D. K., Caprioli, R. M., Choudhary, J., Cruz-Monserrate, Z., Dasyam, A. K., Forsmark, C. E., Gorelick, F. S., Gray, J. W., Haupt, M., et al. (2019) · Pancreas · doi:10.1097/mpa.0000000000001412 · Cited by 15

The Role of the Tumor Microenvironment in Pancreatic Ductal Adenocarcinoma: Recent Advancements and Emerging Therapeutic Strategies

Glapiński, F., Zając, W., Fudalej, M. M., Deptała, A., Czerw, A. I., Sygit, K., Kozłowski, R., & Badowska-Kozakiewicz, A. M. (2025) · Cancers · doi:10.3390/cancers17101599 · Cited by 15

Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma

Dong, M., Tang, R., Wang, W., Xu, J., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., Zhang, B., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101692 · Cited by 13

Opposing roles for ADAMTS2 and ADAMTS14 in myofibroblast differentiation and function

Carter, E. P., Yoneten, K. K., Gavara, N., Tyler, E. J., Gauthier, V., Murray, E. R., ten Dijke, P., Cameron, A. J. M., Pearce, O. M. T., & Grose, R. P. (2023) · The Journal of Pathology · doi:10.1002/path.6214 · Cited by 15

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma

Naso, J. R., Topham, J. T., Karasinska, J. M., Lee, M. K. C., Kalloger, S. E., Wong, H., Nelson, J., Moore, R. A., Mungall, A. J. J., Jones, S. J. M., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3695 · Cited by 13

Organoids at the PUB: The Porcine Urinary Bladder Serves as a Pancreatic Niche for Advanced Cancer Modeling

Melzer, M. K., Breunig, M., Arnold, F., Wezel, F., Azoitei, A., Roger, É., Krüger, J., Merkle, J., Schütte, L. D., Resheq, Y. J., et al. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102345 · Cited by 15

Cellular states associated with metastatic organotropism and survival in patients with pancreatic ductal adenocarcinoma

Hajkarim, M. C., May, M. S., Amin, A. D., Jamison, J. K. R., Tagore, S., D’Souza, E. K., Caprio, L., Walsh, Z. H., Fan, J. L., Zhang, M., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02345-5 · Cited by 13

Pathology and Molecular Characteristics of Pancreatic Cancer

Kearney, J. F., Adsay, V. N., & Yeh, J. J. (2021) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2021.06.003 · Cited by 15

Heterogeneity in Pancreatic Cancer Fibroblasts—TGFβ as a Master Regulator?

Watt, D. M., & Morton, J. P. (2021) · Cancers · doi:10.3390/cancers13194984 · Cited by 12

Molecular, metabolic, and histological subtypes of pancreatic ductal adenocarcinoma and its tumor microenvironment: Insights into tumor heterogeneity and clinical implications

Ohara, Y., Liu, H., Moreno, P., Suzuki, S., & Hussain, S. P. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108946 · Cited by 11

Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease

Monkman, J. H., Thompson, E. W., & Nagaraj, S. H. (2019) · Cancers · doi:10.3390/cancers11111745 · Cited by 12

Eicosanoids in the Pancreatic Tumor Microenvironment—A Multicellular, Multifaceted Progression

Gubbala, V. B., Jytosana, N., Trinh, V. Q., Maurer, H. C., Naeem, R. F., Lytle, N. K., Ma, Z., Zhao, S., Lin, W., Han, H., et al. (2022) · Gastro Hep Advances · doi:10.1016/j.gastha.2022.02.007 · Cited by 11

Transcriptional deconvolution reveals consistent functional subtypes of pancreatic cancer epithelium and stromaPreprint

He, J., Maurer, H. C., Holmstrom, S. R., Su, T., Ahmed, A., Hibshoosh, H. H., Chabot, J. A., Oberstein, P. E., Sepulveda, A. R., Genkinger, J. M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/288779 · Cited by 4

Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma

Moffitt, R. A., Marayati, R., Flate, E. L., Volmar, K. E., Loeza, S. G. H., Hoadley, K. A., Rashid, N. U., Williams, L. A., Eaton, S. C., Chung, A. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3398 · Cited by 2,194

Transcriptomic Analysis of Laser Capture Microdissected Tumors Reveals Cancer- and Stromal-Specific Molecular Subtypes of Pancreatic Ductal Adenocarcinoma

Birnbaum, D. J., Begg, S. K. S., Finetti, P., Vanderburg, C. R., Kulkarni, A. S., Neyaz, A., Hank, T. P., Tai, E. C., Deshpande, V., Bertucci, F., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1039 · Cited by 27

Including the stromal compartment in PDAC classification

(2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.165

Stratification of pancreatic ductal adenocarcinomas based on tumor and microenvironment features

Puleo, F., Nicolle, R., Blum, Y., Cros, J., Marisa, L., Demetter, P., Quertinmont, E., Svrcek, M., Elarouci, N., Iovanna, J., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.033 · Cited by 563